Lynn Seely
2017
In 2017, Lynn Seely earned a total compensation of $12.2M as Principal Executive Officer at Myovant Sciences Ltd., a 96% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $230,400 |
|---|---|
| Option Awards | $3,404,171 |
| Salary | $525,569 |
| Stock Awards | $7,999,094 |
| Total | $12,159,234 |
Seely received $8M in stock awards, accounting for 66% of the total pay in 2017.
Seely also received $230.4K in non-equity incentive plan, $3.4M in option awards and $525.6K in salary.
Rankings
In 2017, Lynn Seely's compensation ranked 437th out of 14,666 executives tracked by ExecPay. In other words, Seely earned more than 97.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 437 out of 14,666 | 97th |
Division Manufacturing | 139 out of 5,768 | 98th |
Major group Chemicals And Allied Products | 34 out of 2,074 | 98th |
Industry group Drugs | 24 out of 1,730 | 99th |
Industry Pharmaceutical Preparations | 21 out of 1,329 | 98th |
Source: SEC filing on July 25, 2018.
Seely's colleagues
We found two more compensation records of executives who worked with Lynn Seely at Myovant Sciences Ltd. in 2017.